Cassady Schiller Wealth Management’s Exact Sciences EXAS Stock Holding History

Cassady Schiller Wealth Management’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$56	Buy	+1	New	+$62	﹤0.01%	1126

Other funds holding EXAS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cassady Schiller Wealth Management's EXAS Position: Q4 2024 in Review

Cassady Schiller Wealth Management opened a new position in Exact Sciences (EXAS) in Q4 2024: 1 share worth $56. The stake represents ﹤0.01% of the portfolio and ranks #1126 among its holdings.

592 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

Cassady Schiller Wealth Management held 1 share of Exact Sciences worth $56 as of Q4 2024.
Exact Sciences was a new Cassady Schiller Wealth Management position in Q4 2024.
Exact Sciences made up ﹤0.01% of Cassady Schiller Wealth Management's portfolio in Q4 2024, its #1126 holding.
592 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Cassady Schiller Wealth Management's 13F filing for Q4 2024, filed 10 Feb 2025.